Observational studies in humans report lower circulating spexin levels in obesity and metabolic syndrome, supporting its role as an endogenous metabolic regulator rather than a stress-induced peptide ( More recent analyses suggest that spexins metabolic actions may be dissociable from its nociceptive or affective effects through receptor subtype selectivity and dosing strategies ( 4.3 Meteorin-like protein (METRNL) and exercise-induced endocrinology Meteorin-like protein (METRNL) occupies a distinct conceptual niche within metabolic peptide biology
additive with GLP-1 Semaglutide Established CV outcomes Tirzepatide Highest single-agent obesity efficacy Retatrutide Triple-agonist mechanism Numbers reflect published Phase 3 endpoints where available
More about Zepbound (tirzepatide) Check interactions Compare alternatives Pricing & coupons Reviews (726) Drug images Latest FDA alerts (3) Side effects Dosage information During pregnancy Support group FDA approval history Drug class: GLP-1 Drugs Breastfeeding En espaol Patient resources Professional resources Other brands Related treatment guides Copyright 2023, 2026, Eli Lilly and Company
Wanting to feel attractive is not a moral failure
in misuse scenarios, cardiomegaly has been reported
Unlike injectable versions, oral semaglutide provides greater convenience and improved patient compliance